Právní předpis byl sestaven k datu 25.10.2026.
Zobrazené znění právního předpisu je účinné od 17.12.2016.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2017
390/2016 Sb.
390
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 28. xxxxxxxxx 2016
x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx pro xxx 2017
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 odst. 1 xxxx. e) xxxxxx x. 258/2000 Xx., x xxxxxxx veřejného xxxxxx a x xxxxx některých xxxxxxxxxxxxx xxxxxx, xx znění xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx komise xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2017:
1. Antiqenní xxxxxxx xxxxxxxxxx látek pro xxxxxxxxxx očkování
1a) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx x (DTaPHibVHBIPV):
Diphtheriae xxxxxxxxxx1 ne xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxx anatoxinum1 xx xxxx než 40 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxxxx Xxxxxxxxxx pertussis:
Pertussis xxxxxxxxxx1 25 mikrogramů
Haemagglutininum xxxxxxxxxxxx1 25 xxxxxxxxxx
Xxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxx (xxxxxxxxxxxx)
xxxxx 1 (kmen Xxxxxxx)4 40 X jednotek xxxxxxxx
xxxxx 2 (xxxx XXX-1)4 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx x xxxxxxxxxxxxxxx 10 xxxxxxxxxx
(xxxxxxxxxxxxxxxxxxx xxxxxxxx)3
xxxxxxxxx xxx tetani xxxxxxxxxx xxxx nosným xxxxxxxxx přibližně 25 xxxxxxxxxx
XXXX
1xx) kombinovaná xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xxxxxxxxxxx xxxxxxxxxx xx xxxx než 20 mezinárodních xxxxxxxx (XX)2
Xxxxxx anatoxinum xx xxxx xxx 40 xxxxxxxxxxxxx jednotek (IU)2
Antigeny Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Xxxxxxx) 40 X xxxxxxxx xxxxxxxx4
xxxxx 2 (MEF-1) 8 X xxxxxxxx xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 D jednotek xxxxxxxx4
Xxxxxxxxx xxxxxxxxx hepatitidy X5 10 xxxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxx x xxxxxxxxxxxxxxx 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx xxx xxxxxx xxxxxxxxxx 22-36 mikrogramů
1b) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx (XXxX):
Xxxxxxxxxxx anatoxinum ³ 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx ³ 40 xxxxxxxxxxxxx jednotek
Pertussis xxxxxxxxxx (XX) 25 mikrogramů
Pertussis xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx (69xX) 8 mikrogramů
NEBO
1ba) Xxxxxxxx xxxxx xxxxx záškrtu, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx)
|
1 xxxxx (0,5 ml) obsahuje: Xxxxxxxxxxx xxxxxxxxxx |
Xxxxxxxxx 2 XX* (2 Xx) |
|
Xxxxxx xxxxxxxxxx |
Xxxxxxxxx 20 XX* (5 Lf) |
|
Pertusové xxxxxxxx |
|
|
Xxxxxxxxx xxxxxxxxxx |
2,5 xxxxxxxxxx |
|
Xxxxxxxxxxxxxx filamentosum |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx |
3 xxxxxxxxxx |
|
Xxxxxxxx, xxxx 2 et 3 |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx |
1,5 xx (0,33 xx xxxxxxx) |
XXXX
1xx) Očkovací xxxxx xxxxx xxxxxxx, xxxxxx a xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx než 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx anatoxinum1 xx méně xxx 20 mezinárodních xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx antigena:
Pertussis xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx proteinum1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx (AI(OH)3) 0,3 xxxxxxxxx XX3+
x xxxxxxxxxxx xxxxxxx (XXX04) 0,2 xxxxxxxxx XX3+
1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
|
Xxxxxxxxxxx xxxxxxxxxx |
xxx. 30 xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxx xxxxxxxxxx |
xxx. 40 xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxx anatoxinum (XX) |
25 xxxxxxxxxx |
|
Xxxxxxxxx haemaglutininum xxxxxxxxxxxx |
(XXX) 25 mikrogramů |
|
Pertactinum (69xX) |
8 xxxxxxxxxx |
|
Xxxxxxxxxxx xxxxxxxxxx B |
10 xxxxxxxxxx |
|
xxx xxxxxxxxx xxxxxxxx |
20-40 xxxxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx nákazám vyvolaným Xxxxxxxxxxx influenzae typ x:
1 dávka xxxxxxxxxxxxx xxxxxxx obsahuje: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) cum Anatoxino xxxxxxxx (přibližně 25 xxxxxxxxxx).
1x) xxxxxxxx látka xxxxx xxxxxx:
Xxxxxx xxxxxxxxxx … min. 40 xxxxxxxxxxxxx jednotek
1f) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B xx 16 let x xxxx:
|
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X |
20 mikrogramů |
1g) xxxxxxxx xxxxx proti virové xxxxxxxxxx X x xxxxxx xxxxxxx:
|
Xxxxxxxxx tegiminis xxxxxxxxxxx B |
10 xxxxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx (Xxxxxxx) min. 103,0 xxxxxxxx dávka xxx xxxxxxxx kulturu50 Xxxxxxxxxxx xxxxx xxxxxxxxxx (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx50 Xxxxxxxx xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx50
1xx) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx obrně x inaktivované xxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Mahoney) … 40 xxxxxxxxxxx D xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (MEF-1) … 8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) … 32 xxxxxxxxxxx D jednotek*
* xxxx xxxxxxxx ekvivalentních xxxxxxxx stanovené pomocí xxxxxx imunochemické xxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:
Xxxxxxxxxxxxxxx Streptococci xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10X, 11X, 12X, 14, 15X, 17X,
18X, 19X, 19F, 20, 22X, 23X, 33X … 25 xxxxxxxxxx x každého xxxxxxxx
1x) očkovací xxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 3
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 4
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X
Xxxxxxxxxxxxx polysaccharidum sérotypus 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 14
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 18X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1x) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (inaktivovaná forma):
|
Xxxxxxxxxxx anatoxinum |
ne méně xxx 2 mezinárodní xxxxxxxx |
|
Xxxxxx xxxxxxxxxx |
xx xxxx xxx 20 mezinárodních xxxxxxxx |
|
Xxxxxxxxx antigeny: |
|
|
Pertussis xxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx |
2,5 xxxxxxxxxx |
|
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx: |
|
|
xxxxx 1 (kmen Xxxxxxx) |
40 X jednotek xxxxxxxx |
|
xxxxx 2 (kmen XXX-1) |
8 X xxxxxxxx xxxxxxxx |
|
xxxxx 3 (xxxx Xxxxxxx) |
2 X jednotek xxxxxxxx |
XXXX
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx forma):
|
Difterický xxxxxx |
xxxx xxxx rovno 2 mezinárodní xxxxxxxx (2 Xx) |
|
Xxxxxxxxx toxoid |
více xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx) |
|
Xxxxxxxxx antigeny: |
|
|
Xxxxxxxxx xxxxxx |
2,5 mikrogramu |
|
Filamentózní xxxxxxxxxxxx |
5 xxxxxxxxxx |
|
&xxxx;&xxxx; Xxxxxxx xxxx 2+3 |
5 mikrogramů |
|
Xxxxxxxxx |
3 mikrogramy |
|
Virus poliomyelitis xxxx 1 (inaktivovaný) |
40 xxxxxxxxxxx X jednotek |
|
Virus xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) |
8 antigenních X xxxxxxxx |
|
Xxxxx poliomyelitis xxxx 3 (xxxxxxxxxxxx) |
32 xxxxxxxxxxx X xxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx (XXX vakcína)
1n) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X pro xxxxx zařazené xx xxxxxxxxxxxx programu:
Antigenum xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx X (XXX) 50 xxxxxxxxxx x 1 xxxxx
2. Antigenní xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxx
2x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
|
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B |
20 xxxxxxxxxx |
2x) očkovací xxxxx xxxxx vzteklině
2c) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx A xx xxxxxxx pro xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx xxxxxxx:
Xxxxxxxxx A xxxxx xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
X xxxx 2017 s xxxxxxx xx plánovanou xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x xxxxxxxx xxxxx xxxxxxxxx xxxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxxxx očkování xxxxxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx xxxxxx očkovacích látek xx Xxxxxx xxxxxx.
Xxxxxxx:
XXXx. Xxxxxxx, XXX, v. x.
Xxxxxxxxx
Xxxxxx xxxxxxx č. 390/2016 Sb. xxxxx xxxxxxxxx dnem 17.12.2016.
Ke xxx xxxxxxxx právní xxxxxxx xxxxx měněn xx xxxxxxxxx.
Xxxxx jednotlivých xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx není aktualizováno, xxxxx xx jich xxxxxx derogační změna xxxxx xxxxxxxxx právního xxxxxxxx.